Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
426 Results Found
Judge: HHS has authority to preapprove implementation of 340B ‘rebate models’
A U.S. district court judge for the District of Columbia May 15 ruled the Department of Health and Human Services must preapprove the use of 340B “rebate models” before they can be implemented, which the department has not yet done for any of the models pursued by the plaintiff drug companies.
AHA Rural Health News Update - September 21, 2023
A compilation of recent news from the AHA and its Rural Health Services team, whose focus is to ensure that rural hospitals’ and health systems’ unique needs are national priorities.
AHA files brief defending South Dakota’s 340B contract pharmacy law
The AHA May 14 filed an amicus brief in the U.S. District Court for the District of South Dakota in defense of the state’s 340B contract pharmacy law prohibiting drug companies from denying hospitals the same 340B discounts for drugs dispensed at community pharmacies that would be provided via in-house pharmacies.
CMS releases draft guidance for third cycle of Medicare drug price negotiations
The Centers for Medicare & Medicaid Services May 12 released
House Ways and Means Committee advances its portion of FY 2025 reconciliation bill
The House Ways and Means Committee today advanced its portion of the fiscal year 2025 reconciliation bill by a 26-19 vote along party lines, following an hours-long, overnight markup.
AHA comments to HHS on 340B drug rebate models
The AHA May 9 urged the Department of Health and Human Services to deny drug companies’ requests to approve their unlawful 340B rebate models.
AHA shares concerns on data exchange provision under drug price negotiation program
The AHA May 1 expressed concerns to the Centers for Medicare & Medicaid Services about the payment process established under the Medicare Drug Price Negotiation Program, explaining ways it undermines the purpose of the 340B Drug Pricing Program.
AHA comments on House Ways and Means Committee markup
The House Ways and Means Committee May 13 began to mark up its portion of the fiscal year 2025 reconciliation bill, with some proposals impacting the health care field.
AHA files brief in defense of Nebraska’s 340B contract pharmacy law
The AHA May 8 filed an amicus brief in the U.S. District Court for the District of Nebraska in defense of the state’s 340B contract pharmacy law prohibiting drug companies from denying hospitals the same 340B discounts for drugs dispensed at community pharmacies that would be provided via in-house pharmacies.